Besides, BCRP was reported to mediate drug resistance in hepatoma cells under the transcriptional control of Gli1/2, and the inhibition of Gli1 or ABCB2 gene expression ameliorated resistance to various chemotherapies in hepatoma cells[163]. Here, GLI1 is linked to hepatocellular carcinoma.